MLMIC’s Board of Directors has approved a 20 percent dividend for all MLMIC policyholders.
Medscape data offers some perspective related to medical liability and malpractice litigation.
Given recent stories about insurers exiting the New York market due to financial difficulties, it is reassuring to know that New York’s leading medical liability insurer is sound and ready to serve its policyholders.
From beginning to end, the claims process (which may or may not be resolved in a trial) is long and can be quite grueling. However, it can make a difference to have confidence that you’re in attentive and capable hands.